Actively Recruiting
Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial Aneurysms
Led by First Affiliated Hospital of Zhejiang University · Updated on 2026-01-29
164
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Using data obtained from the treatment of intracranial distal intracranial aneurysms with flow diverter, evaluate the effecy and safety of blood flow diverter for the endovascular treatment of distal intracranial aneurysms.
CONDITIONS
Official Title
Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial Aneurysms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 80 years, any gender, treated with flow-diverting stents for distal intracranial aneurysms
- Diagnosed with an intracranial aneurysm by CTA, MRA, or DSA with wide neck (≥4mm), dome-to-neck ratio <2, including saccular, fusiform, recurrent saccular, and dissecting aneurysms
- Aneurysm location includes Circle of Willis and its distal branches such as MCA M1-M3, ACA A1-A3, PCA P1-P2 segments
- Subject or guardian can understand the study purpose, complies with protocol, and provides signed informed consent
You will not qualify if you...
- Conditions unsuitable for stent delivery judged by investigators (severe parent artery stenosis or tortuosity, stent delivery failure, or stent placement issues)
- Modified Rankin Scale score ≥3
- Severe heart, lung, liver, or kidney failure or other serious diseases (intracranial tumor, systemic infection, coagulation disorders, recent myocardial infarction, severe psychosis, severe cerebral artery stenosis or occlusion)
- Platelet count <60×10^9/L, platelet dysfunction, or INR >1.5
- Major surgery within 30 days before enrollment or planned surgery within 360 days after enrollment
- Allergies or contraindications to anesthetics, anticoagulants, or antiplatelet drugs
- Pregnant or breastfeeding women
- Participation in other clinical trials within 1 month before consent
- Other conditions deemed unsuitable by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
Research Team
Y
yuanyuan Shen
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here